Carisma Therapeutics, Inc.CARMNASDAQ

Revenue (LTM)

$20M

+31.6% YoY

Net Income (LTM)

$-60M

+30.4% YoY

Free Cash Flow

$-60M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	11	27↑136.2%	10↓63.0%	15↑51.7%	20↑31.6%
Gross Profit	11	26↑135.5%	10↓62.8%	-59↓702.1%	-40↑32.4%
Operating Income	-28	-28↑0.8%	-56↓99.4%	-89↓58.0%	-62↑29.9%
Net Income	-28	-0↑98.8%	-61↓18122.0%	-87↓41.9%	-60↑30.4%
EBITDA	-28	-9↑69.5%	-56↓559.2%	-86↓52.9%	-57↑33.8%
EPS Diluted	-3.81	-0.04↑99.0%	-1.52↓4030.4%	-2.59↓70.4%	-1.46↑43.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	55	163↑193.6%	24↓85.1%	78↑220.8%	18↓76.9%
Total Current Assets	63	206↑227.0%	55↓73.4%	80↑47.4%	24↓70.4%
Total Assets	188	313↑65.9%	72↓76.9%	90↑24.1%	30↓66.0%
Total Current Liabilities	18	12↓35.9%	20↑70.0%	16↓19.1%	16↑0.9%
Total Liabilities	198	141↓28.7%	215↑52.5%	63↓70.7%	58↓7.4%
Total Equity	-9	172↑1961.0%	-157↓191.5%	27↑116.9%	-28↓205.2%
Total Debt	0	0	40	3↓92.2%	2↓20.6%
Net Debt	-55	-163↓193.6%	16↑109.8%	-74↓566.4%	-15↑79.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-27	-37↓38.2%	-8↑79.7%	-81↓972.9%	-60↑26.2%
Capital Expenditure	-0	-2↓325.2%	-5↓149.1%	-1↑75.7%	-0↑89.1%
Free Cash Flow	-27	-39↓42.8%	-12↑68.8%	-82↓573.2%	-60↑27.1%
Stock-Based Comp	0	0↑193.9%	0	2	4↑57.6%
Net Change in Cash	45	-23↓151.9%	-138↓495.8%	53↑138.6%	-60↓211.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance